Effect of COVID-19 vaccine on menstrual health
We are working on three projects to understand the effect of COVID-19 vaccine on the menstrual cycle. These projects are funded by the National Institute of Health (NIH).
​
Prospective data collection:​
-
Enrolling participants who will receive the COVID-19 vaccine for the first time or the COVID-19 booster vaccine
-
Information regarding the menstrual cycle, stress levels, and hormonal treatment before and after the vaccination will be collected
-
Participants must be between the ages 18-55 and have had at least one menstrual cycle in the past 12 months
-
Details: www.covidmenses.org. If you are considering enrollment, please sign up on the website.
​
Cellular studies:
-
Enrolling participants who will receive the COVID-19 vaccine for the first time or the COVID-19 booster vaccine
-
Menstrual effluent (product) will be collected at Johns Hopkins University from one cycle before and after the vaccination to check chemokine and cytokine levels as well as the immune profile of the menstrual effluent
-
Information regarding the menstrual cycle, stress levels, and hormonal treatment before and after the vaccination will be collected
-
Participants must be between the ages 18-55 and have had at least one menstrual cycle in the past 12 months
-
Details: www.covidmenses.org. If you are considering enrollment, please sign up on the website.
​
Large data set analysis:
-
Using a popular period tracking application to compare the menstrual cycles of users before and after they received the COVID-19 vaccine
Simvastatin clinical trial
-
A Double-blinded, Phase II, Randomized Control Trial to Study the Effects of Simvastatin in Patients With Uterine Leiomyoma
-
Enrolling patients with fibroids who is planning surgery
-
Performed at Johns Hopkins Hospitals in Baltimore
-
Funded by National Institutes of Health
-
If you are considering enrollment, please contact us.